European stocks are likely to start positive as AstraZeneca's COVID-19 vaccine has been approved for emergency supply in the UK, despite mixed Asian performance and the negative cues from Wall Street amid uncertainty about whether the U.S. Senate would approve planned increase in stimulus checks.
The UK Medicines and Healthcare products Regulatory Agency has approved AstraZeneca's COVID-19 vaccine for emergency supply in the UK, with the first doses being released today. The vaccinations may begin early in the New Year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.